Artificial Intelligence Systems in CKD: Where Do We Stand and What Will the Future Bring?
Advances in Chronic Kidney Disease · 2022-09 · 29 (5) · 461-464
DOI: 10.1053/j.ackd.2022.06.004 ↗Kurz gefasst
Editorial in der Zeitschrift Advances in Chronic Kidney Disease, 2022-09. Verfasst von Arjun Ananda Padmanabhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Information University of Michigan Ann Arbor, MI. Hauptthemen laut MEDLINE: Artificial Intelligence, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Teva Pharmaceutical Industries.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Information University of Michigan Ann Arbor, MI.
- Medical Scientist Training Program University of Michigan Medical School Ann Arbor, MI.
- School of Information University of Michigan Ann Arbor, MI; Department of Learning Health Sciences University of Michigan Medical School Ann Arbor, MI; Department of Internal Medicine University of Michigan Medical Scho…
Förderung
- Teva Pharmaceutical Industries
Zitieren
APA
Ananda Padmanabhan, A., Balczewski, E. A., & Singh, K. (2022). Artificial Intelligence Systems in CKD: Where Do We Stand and What Will the Future Bring?. Advances in Chronic Kidney Disease, 29(5), 461-464. https://doi.org/10.1053/j.ackd.2022.06.004
Vancouver
Ananda Padmanabhan A, Balczewski EA, Singh K. Artificial Intelligence Systems in CKD: Where Do We Stand and What Will the Future Bring?. Advances in Chronic Kidney Disease. 2022;29(5):461-464. doi:10.1053/j.ackd.2022.06.004
BibTeX
@article{AnandaPadmanabhan2022,
author = {Ananda Padmanabhan, Arjun and Balczewski, Emily A and Singh, Karandeep},
title = {Artificial Intelligence Systems in CKD: Where Do We Stand and What Will the Future Bring?},
journal = {Advances in Chronic Kidney Disease},
year = {2022},
volume = {29},
number = {5},
pages = {461--464},
doi = {10.1053/j.ackd.2022.06.004}
}
EUVIMED